AlzeCure Pharma AB (publ)
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
| Przychód (średnia) |
29.00 |
20.00 |
6.75 |
20.00 |
| Przychód Δ r/r |
0.00% |
-31.03% |
-66.25% |
196.30% |
| Przychód (min) |
29.00 |
20.00 |
6.75 |
20.00 |
| Przychód (max) |
29.00 |
20.00 |
6.75 |
20.00 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-29.32 |
-29.32 |
-21.99 |
-65.98 |
| Zysk netto % |
-101.11% |
-146.61% |
-325.81% |
-329.88% |
| EPS (średnia) |
-0.38 |
-0.38 |
-0.29 |
-0.86 |
| Liczba analityków (Przychody) |
1 |
1 |
1 |
1 |
| Liczba analityków (EPS) |
1 |
1 |
1 |
1 |
| symbol |
ALZCUR.ST |
ALZCUR.ST |
ALZCUR.ST |
ALZCUR.ST |